Autologous human preclinical modeling of melanoma interpatient clinical responses to immunotherapeutics

Autologous human preclinical modeling of melanoma interpatient clinical responses to immunotherapeutics

Background Despite recent advances in immunotherapy, a substantial population of late-stage melanoma patients still fail to achieve sustained clinical benefit. Lack of translational preclinical models continues to be a major challenge in the field of immunotherapy; thus, more optimized translational...

Full description

Bibliographic Details
Main Authors: Lukas W Pfannenstiel, Brian R Gastman, Jennifer S Ko, Marc S Ernstoff, Pauline Funchain, Yee Peng Phoon, Jared E Lopes, Heather C Losey, Claudia Marcela Diaz-Montero, Ye F Tian, Raymond Winquist, Jan Joseph Melenhorst
Format: Article
Language:English
Published: BMJ Publishing Group 2024-04-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/12/4/e008066.full

Internet

https://jitc.bmj.com/content/12/4/e008066.full

Similar Items